Patents by Inventor Lynne M. Georgopoulos

Lynne M. Georgopoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of modified vasoactive intestinal peptides in the treatment of hypertension
    Patent number: 10940182
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: March 9, 2021
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold
  • USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION
    Publication number: 20170072021
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Application
    Filed: September 26, 2016
    Publication date: March 16, 2017
    Inventors: Lynne M. GEORGOPOULOS, Susan ARNOLD
  • Use of modified vasoactive intestinal peptides in the treatment of hypertension
    Patent number: 9561262
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: February 7, 2017
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold
  • METHODS AND TREATMENT WITH GLP-1 RECEPTOR AGONISTS
    Publication number: 20150111816
    Abstract: The invention provides methods for treating diabetes or obesity, as well as methods for inducing weight loss, preventing weight gain, or controlling weight in a patient in need thereof. The methods comprise administering to the patient at least one effective dose of a GLP-1 receptor agonist, or a regimen of GLP-1 receptor agonist comprising a plurality of substantially evenly spaced doses. The effective dose or regimen does not induce substantial nausea or appetite suppression in the patient.
    Type: Application
    Filed: January 23, 2014
    Publication date: April 23, 2015
    Applicant: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. GEORGOPOULOS, Sue Sue
  • USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION
    Publication number: 20150111829
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Application
    Filed: June 6, 2012
    Publication date: April 23, 2015
    Applicant: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold
  • METHODS OF TREATMENT WITH GLP-1 RECEPTOR AGONISTS
    Publication number: 20130090285
    Abstract: The invention provides methods for treating diabetes or obesity, as well as methods for inducing weight loss, preventing weight gain, or controlling weight in a patient in need thereof. The methods comprise administering to the patient at least one effective dose of a GLP-1 receptor agonist, or a regimen of GLP-1 receptor agonist comprising a plurality of substantially evenly spaced doses. The effective dose or regimen does not induce substantial nausea or appetite suppression in the patient.
    Type: Application
    Filed: June 27, 2012
    Publication date: April 11, 2013
    Applicant: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold